loading
Precedente Chiudi:
$0.751
Aprire:
$0.7285
Volume 24 ore:
154.68K
Relative Volume:
1.20
Capitalizzazione di mercato:
$86.53M
Reddito:
-
Utile/perdita netta:
$-70.78M
Rapporto P/E:
-1.2169
EPS:
-0.56
Flusso di cassa netto:
$-61.27M
1 W Prestazione:
-23.06%
1M Prestazione:
-43.57%
6M Prestazione:
-74.80%
1 anno Prestazione:
-74.13%
Intervallo 1D:
Value
$0.668
$0.7285
Intervallo di 1 settimana:
Value
$0.668
$0.8996
Portata 52W:
Value
$0.668
$3.09

Nautilus Biotechnology Inc Stock (NAUT) Company Profile

Name
Nome
Nautilus Biotechnology Inc
Name
Telefono
206-333-2001
Name
Indirizzo
2701 EASTLAKE AVE EAST, SEATTLE
Name
Dipendente
155
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-29
Name
Ultimi documenti SEC
Name
NAUT's Discussions on Twitter

Confronta NAUT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NAUT
Nautilus Biotechnology Inc
0.6816 86.53M 0 -70.78M -61.27M -0.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
481.68 125.40B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
587.39 65.79B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
559.38 35.18B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
244.97 32.67B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
240.59 26.46B 3.81B -644.79M -669.77M -6.24

Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-05 Downgrade Goldman Neutral → Sell
2024-06-27 Iniziato Guggenheim Buy
2024-06-03 Ripresa Jefferies Hold
2022-01-06 Iniziato Morgan Stanley Equal-Weight
2021-11-02 Iniziato Cowen Outperform
2021-08-04 Iniziato Goldman Neutral
2021-07-13 Iniziato Jefferies Buy
Mostra tutto

Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie

pulisher
Apr 02, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Stock Position Decreased by Charles Schwab Investment Management Inc. - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Takes $28,000 Position in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

We're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate - Yahoo Finance

Mar 31, 2025
pulisher
Mar 12, 2025

Nautilus Biotechnology: Hold Rating Amid Delayed Launch and Strategic Adjustments - TipRanks

Mar 12, 2025
pulisher
Mar 03, 2025

Nautilus Biotechnology’s Earnings Call: Progress Amid Challenges - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 03, 2025
pulisher
Mar 01, 2025

Nautilus Biotechnology lays off 16% of workforce, plans release of commercial platform in 2026 - MSN

Mar 01, 2025
pulisher
Feb 28, 2025

Nautilus: Trading Below An Albeit Lower Net Cash Figure (NASDAQ:NAUT) - Seeking Alpha

Feb 28, 2025
pulisher
Feb 28, 2025

Guggenheim cuts Nautilus Biotech target to $2.50, keeps buy rating - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

Guggenheim cuts Nautilus Biotech target to $2.50, keeps buy rating By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 27, 2025

Nautilus Biotechnology Reports 2024 Financial Results - TipRanks

Feb 27, 2025
pulisher
Feb 27, 2025

Seattle's Nautilus Biotechnology lays off 16% of its staff - The Business Journals

Feb 27, 2025
pulisher
Feb 27, 2025

Nautilus Biotechnology Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 27, 2025
pulisher
Feb 27, 2025

Earnings call transcript: Nautilus Q4 2024 highlights platform delay - Investing.com

Feb 27, 2025
pulisher
Feb 27, 2025

Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024 - Marketscreener.com

Feb 27, 2025
pulisher
Feb 27, 2025

Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2024 Financial Results - The Manila Times

Feb 27, 2025
pulisher
Feb 27, 2025

Nautilus Cuts 16% of Workforce as Biotech Platform Launch Slips to 2026What's Next? - StockTitan

Feb 27, 2025
pulisher
Feb 27, 2025

Nautilus Biotechnology Announces Board Changes for 2025 - TipRanks

Feb 27, 2025
pulisher
Feb 23, 2025

Nautilus Biotechnology (NAUT) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 23, 2025
pulisher
Feb 18, 2025

Blade Air Mobility Leads The Charge Among 3 US Penny Stocks - Simply Wall St

Feb 18, 2025
pulisher
Feb 18, 2025

Nautilus Biotechnology to Participate in the TD Cowen 45th Annual Healthcare Conference - The Manila Times

Feb 18, 2025
pulisher
Feb 18, 2025

Exclusive: Nautilus Biotech Unveils Next-Gen Protein Analysis Breakthrough at Major Healthcare Summit - StockTitan

Feb 18, 2025
pulisher
Feb 16, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Down 68.8% in January - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Nautilus Biotechnology (NASDAQ:NAUT) Stock Price Down 5.9%Time to Sell? - MarketBeat

Feb 16, 2025
pulisher
Feb 15, 2025

SG Americas Securities LLC Buys 9,904 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Feb 15, 2025
pulisher
Feb 06, 2025

NAUTNautilus Biotechnology Inc Latest Stock News & Market Updates - StockTitan

Feb 06, 2025
pulisher
Feb 06, 2025

Nautilus Bio Q4 Earnings Alert: Protein Analysis Pioneer Reports Feb 27 - StockTitan

Feb 06, 2025
pulisher
Feb 06, 2025

Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewswire

Feb 06, 2025
pulisher
Feb 06, 2025

One Nautilus Biotechnology Insider Raised Their Stake In The Previous Year - Yahoo Canada Finance

Feb 06, 2025
pulisher
Feb 01, 2025

Nautilus Biotech announces board member changes By Investing.com - Investing.com Australia

Feb 01, 2025
pulisher
Feb 01, 2025

Nautilus Biotech announces board member changes - MSN

Feb 01, 2025
pulisher
Feb 01, 2025

Nautilus Biotechnology Announces Board Member Departures - MSN

Feb 01, 2025
pulisher
Jan 26, 2025

NAUTILUS BIOTECHNOLOGY, INC. : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K) - Marketscreener.com

Jan 26, 2025
pulisher
Jan 21, 2025

Barclays PLC Buys 47,059 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jan 21, 2025
pulisher
Jan 20, 2025

Jeff Bezos Stock Portfolio: Top Investment Picks - CoinCodex

Jan 20, 2025
pulisher
Jan 17, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Down 14.2% in December - MarketBeat

Jan 17, 2025
pulisher
Jan 15, 2025

Barclays PLC Has $1.04 Million Holdings in Northfield Bancorp, Inc. (Staten Island, NY) (NASDAQ:NFBK) - Defense World

Jan 15, 2025
pulisher
Jan 15, 2025

Jane Street Group LLC Sells 25,020 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jan 15, 2025
pulisher
Jan 15, 2025

EZCORP, Inc. (NASDAQ:EZPW) Shares Acquired by Barclays PLC - Defense World

Jan 15, 2025
pulisher
Jan 10, 2025

US Penny Stocks To Watch In January 2025 - simplywall.st

Jan 10, 2025
pulisher
Jan 09, 2025

Dermata Therapeutics Inc (DRMA): Major Improvements, Worth A Look - Stocks Register

Jan 09, 2025
pulisher
Jan 06, 2025

Barclays PLC Has $303,000 Stock Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jan 06, 2025
pulisher
Jan 01, 2025

State Street Corp Lowers Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jan 01, 2025
pulisher
Dec 18, 2024

The Manufacturers Life Insurance Company Invests $67,000 in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Dec 18, 2024
pulisher
Dec 12, 2024

US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks - Simply Wall St

Dec 12, 2024

Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Nautilus Biotechnology Inc Azioni (NAUT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Patel Sujal M
CEO, President, and Secretary
Mar 20 '25
Buy
1.00
23,933
23,890
10,141,721
$66.10
price down icon 2.65%
$73.33
price down icon 0.15%
$31.60
price up icon 0.06%
$18.91
price down icon 11.53%
$92.01
price down icon 1.40%
biotechnology ONC
$264.32
price down icon 7.93%
Capitalizzazione:     |  Volume (24 ore):